CNS Drugs

Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder: Current Status of Knowledge
pp. 539-554(16)
Authors: Huang, Yu-Shu; Tsai, Ming-Horng

Enhancing CNS Repair in Neurological Disease: Challenges Arising from Neurodegeneration and Rewiring of the Network
pp. 555-573(19)
Authors: Xu, Xiaohua; Warrington, Arthur E.; Bieber, Allan J.; Rodriguez, Moses

Transdermal Rivastigmine: Management of Cutaneous Adverse Events and Review of the Literature
pp. 575-583(9)
Authors: Greenspoon, Jill; Herrmann, Nathan; Adam, David N.

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder
pp. 585-596(12)
Authors: Abudy, Anat; Juven-Wetzler, Alzbeta; Zohar, Joseph

Issues in the Management of Challenging Behaviours of Adults with Autism Spectrum Disorder
pp. 597-606(10)
Authors: Matson, Johnny L.; Sipes, Megan; Fodstad, Jill C.; Fitzgerald, Mary E.

Rituximab for Secondary Progressive Multiple Sclerosis: A Case Series
pp. 607-613(7)
Authors: Rommer, Paulus S.; Patejdl, Robert; Winkelmann, Alexander; Benecke, Reiner; Zettl, Uwe K.

Vilazodone: In Major Depressive Disorder
pp. 615-627(13)
Author: Frampton, James E.